Stay updated on Dapagliflozin and Metformin in GDM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.

Latest updates to the Dapagliflozin and Metformin in GDM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedCore content updated to include funding and operating status notice and a new version number v3.2.0; previous version v3.1.0 was removed.SummaryDifference3%
- Check18 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1); the 'Back to Top' link was removed.SummaryDifference0.2%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check47 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new related topics on diabetes and metabolic diseases. However, several specific drug-related terms and location details have been removed.SummaryDifference3%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Dapagliflozin and Metformin in GDM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.